San Francisco, CA (PRWEB) November 13, 2014
Medrio, a leading provider of eClinical Software as a Service (SaaS) and Cloud EDC™ for clinical research, today released a joint case study with DataFlex Solutions, a contract research organization providing clinical data management services. The case study examines DataFlex’s search for an EDC solution that would allow them to efficiently deploy mid-study changes in their phase I clinical trials.
“Our expertise is running clinical trials, not IT infrastructure.” said Tom Andor, DataFlex founder and Senior Clinical Data Manager. “Therefore, implementing an EDC tool that allows us to facilitate smooth and easy database build and changes was critical”.
“Medrio’s new product, M-1, specifically caters to our customers running phase I clinical trials.” said Scott Weidley, VP of Sales and Marketing at Medrio. “Working with DataFlex provided us with a great opportunity to see the real world application and benefits of M-1.”
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area.
For more information visit: http://www.medrio.com.
DataFlex Solutions is a contract research organization (CRO) comprised of experienced pharmaceutical data management personnel brought together to provide high quality clinical data management services at a reasonable cost. The DataFlex team has over 15 years of experience in the clinical research environment expanding across pharmaceutical phase I – IV, medical device, government, and investigator initiated studies. Using a dynamic, flexible, remote based model with efficient use of standards and cutting edge reporting tools, DataFlex is able to provide cost effective and innovative solutions to clients.
For more information visit: http://www.dataflexdm.com